OBJECTIVE: Nitric oxide (NO) was speculated to play an important role in the pathophysiology of cerebral ischemia. Minocycline, a tetracycline derivative, reduced inflammation and protected against cerebral ischemia. To study the neuroprotection mechanism of minocycline for vascular dementia, the influences of minocycline on expressions of inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) were observed in the brains of Wistar rats. METHODS: The vascular dementia rat model was established by permanent bilateral common carotid arteries occlusion (BCCAO). Wistar rats were divideded into 3 groups randomly: sham-operation group (S group), vascular dementia model group (M group), and minocycline treatment group (MT group). The behaviour was tested with Morris water maze and open-field task. Expressions of iNOS and eNOS were measured by immunohistochemistry and reverse transcriptase-polymerase chain reaction (RT-PCR). The optical density value was measured by imaging analysis. Percentage of positive cells with iNOS and eNOS expression was analyzed with optical microscope. RESULTS: Minocycline attenuated cognitive impairment. Inducible NOS was significantly down-regulated in MT group, compared with that in M group (P < 0.01), while eNOS was significantly up-regulated, compared with that in M group (P < 0.01). The expressions of iNOS and eNOS in M and MT groups were higher than those in S group (P < 0.01). CONCLUSION: Minocycline can down-regulate the expression of iNOS and up-regulate the expression of eNOS in vascular dementia, which restrains apoptosis and oxidative stress to protect neural function.
OBJECTIVE:Nitric oxide (NO) was speculated to play an important role in the pathophysiology of cerebral ischemia. Minocycline, a tetracycline derivative, reduced inflammation and protected against cerebral ischemia. To study the neuroprotection mechanism of minocycline for vascular dementia, the influences of minocycline on expressions of inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) were observed in the brains of Wistar rats. METHODS: The vascular dementiarat model was established by permanent bilateral common carotid arteries occlusion (BCCAO). Wistar rats were divideded into 3 groups randomly: sham-operation group (S group), vascular dementia model group (M group), and minocycline treatment group (MT group). The behaviour was tested with Morris water maze and open-field task. Expressions of iNOS and eNOS were measured by immunohistochemistry and reverse transcriptase-polymerase chain reaction (RT-PCR). The optical density value was measured by imaging analysis. Percentage of positive cells with iNOS and eNOS expression was analyzed with optical microscope. RESULTS:Minocycline attenuated cognitive impairment. Inducible NOS was significantly down-regulated in MT group, compared with that in M group (P < 0.01), while eNOS was significantly up-regulated, compared with that in M group (P < 0.01). The expressions of iNOS and eNOS in M and MT groups were higher than those in S group (P < 0.01). CONCLUSION:Minocycline can down-regulate the expression of iNOS and up-regulate the expression of eNOS in vascular dementia, which restrains apoptosis and oxidative stress to protect neural function.
Authors: Shan Zhu; Irina G Stavrovskaya; Martin Drozda; Betty Y S Kim; Victor Ona; Mingwei Li; Satinder Sarang; Allen S Liu; Dean M Hartley; Du Chu Wu; Steven Gullans; Robert J Ferrante; Serge Przedborski; Bruce S Kristal; Robert M Friedlander Journal: Nature Date: 2002-05-02 Impact factor: 49.962
Authors: David P Stirling; Kourosh Khodarahmi; Jie Liu; Lowell T McPhail; Christopher B McBride; John D Steeves; Matt S Ramer; Wolfram Tetzlaff Journal: J Neurosci Date: 2004-03-03 Impact factor: 6.167
Authors: Xin Wang; Shan Zhu; Martin Drozda; Wenhua Zhang; Irina G Stavrovskaya; Elena Cattaneo; Robert J Ferrante; Bruce S Kristal; Robert M Friedlander Journal: Proc Natl Acad Sci U S A Date: 2003-08-20 Impact factor: 11.205
Authors: Mario Cibelli; Antonio Rei Fidalgo; Niccolò Terrando; Daqing Ma; Claudia Monaco; Marc Feldmann; Masao Takata; Isobel J Lever; Jagdeep Nanchahal; Michael S Fanselow; Mervyn Maze Journal: Ann Neurol Date: 2010-09 Impact factor: 10.422
Authors: Liz M Leite; Antônio Germano G Carvalho; Pollyanna L F Tavares Ferreira; Igor Xavier Pessoa; Danilo O Gonçalves; Amanda de Araújo Lopes; Jean Guilherme dos Santos Góes; Victor Costa de Castro Alves; Luzia Kalyne A M Leal; Gerly Anne Brito; Glauce S B Viana Journal: Inflammopharmacology Date: 2011-02-25 Impact factor: 4.473
Authors: Fakhreya Y Jalal; Yi Yang; Jeffrey F Thompson; Tamara Roitbak; Gary A Rosenberg Journal: J Cereb Blood Flow Metab Date: 2015-02-25 Impact factor: 6.200
Authors: Gretchen N Neigh; Kate Karelina; Erica R Glasper; Stephanie L K Bowers; Ning Zhang; Phillip G Popovich; A Courtney DeVries Journal: Stroke Date: 2009-09-17 Impact factor: 7.914
Authors: Cai Zhiyou; Yan Yong; Sun Shanquan; Zhang Jun; Huang Liangguo; Yan Ling; Li Jieying Journal: Neurochem Res Date: 2009-01-04 Impact factor: 3.996